4-[3-(4-Carbamimidoylphenoxy)propoxy]benzenecarboximidamide,2-hydroxyethanesulfonic acid

CAS : 140-63-6

Ref. 3D-AAA14063

Informations sur le produit

• Nom: 4-[3-(4-Carbamimidoylphenoxy)propoxy]benzenecarboximidamide,2-hydroxyethanesulfonic acid
• Synonymes: 4,4′-Diamidino-α,ω-diphenoxypropane isethionate, Benzamidine, 4,4′-(trimethylenedioxy)di-, bis(2-hydroxyethanesulfonate), Benzamidine, 4,4′-(trimethylenedioxy)di-, diisethionate, Benzenecarboximidamide, 4,4′-[1,3-propanediylbis(oxy)]bis-, bis(2-hydroxyethanesulfonate), Brolene Drops, Ethanesulfonic acid, 2-hydroxy-, compd. with 4,4'-(trimethylenedioxy)dibenzamidine (2:1), Ethanesulfonic acid, 2-hydroxy-, compd. with 4,4′-(trimethylenedioxy)dibenzamidine, Ethanesulfonic acid, 2-hydroxy-, compd. with 4,4′-[1,3-propanediylbis(oxy)]bis[benzenecarboximidamide] (2:1), M + B 782, M and B 782, Propamidine diisethionate, Propamidine isethionate, Propamidine isthionate, p,p′-(Trimethylenedioxy)dibenzamidine bis(β-hydroxyethanesulfonate), p,p′-(Trimethylenedioxy)dibenzamidine isethionate

Description

4-[3-(4-Carbamimidoylphenoxy)propoxy]benzenecarboximidamide,2-hydroxyethanesulfonic acid (CMX001) is a novel diagnostic agent that can be used to detect the presence of bacteria in skin and eye disorders. CMX001 binds to DNA and inhibits bacterial growth by inhibiting the polymerase chain reaction. It has been shown to have high resistance against most strains of bacteria, including Aerobacter aerogenes and Staphylococcus aureus. CMX001 also has antiviral activity against herpes simplex virus type 1 (HSV-1). This drug is effective as a topical treatment for eye disorders such as conjunctivitis and blepharitis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 564.6 g/mol
• Formule: C₂₁H₃₂N₄O₁₀S₂
• Degré de pureté: Min. 95%